Drug Shortage Report for JAMP-ALPRAZOLAM
Report ID | 71946 |
Drug Identification Number | 02400154 |
Brand name | JAMP-ALPRAZOLAM |
Common or Proper name | Alprazolam |
Company Name | JAMP PHARMA CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ALPRAZOLAM |
Strength(s) | 2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-01-10 |
Estimated end date | 2020-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-02-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-11 | English | Compare |
v2 | 2019-01-11 | French | Compare |
v3 | 2019-03-01 | English | Compare |
v4 | 2019-03-01 | French | Compare |
v5 | 2019-07-08 | English | Compare |
v6 | 2019-07-08 | French | Compare |
v7 | 2020-02-18 | English | Compare |
v8 | 2020-02-18 | French | Compare |
Showing 1 to 8 of 8